Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1995-06-05
1998-06-02
Mosher, Mary E.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
435 691, 435 5, C12P 2102
Patent
active
057598142
ABSTRACT:
The glycoprotein B ("gB") and analogs thereof are provided by recombinant DNA technology. Oligonucleotide sequences are provided coding the glycoprotein, its precursor and fragments thereof. Methods and compositions are disclosed for the production of the glycoprotein and analogous proteins as well as oligonucleotide sequences, which may be used for probes or other applications, and particularly may be used for vaccines.
REFERENCES:
patent: 4172125 (1979-10-01), Audibert et al.
patent: 4317811 (1982-03-01), Bertland et al.
patent: 4374127 (1983-02-01), Larson et al.
patent: 4452734 (1984-06-01), Larson et al.
patent: 4606918 (1986-08-01), Allison et al.
patent: 4642333 (1987-02-01), Person
patent: 4661349 (1987-04-01), Kino et al.
patent: 4724146 (1988-02-01), Kino et al.
patent: 4891315 (1990-01-01), Watson et al.
patent: 5171568 (1992-12-01), Burke et al.
patent: 5244792 (1993-09-01), Burke et al.
Burke et al. The Influence of Adjuvants on the Therapeutic Efficacy of a Recombinat Genital Herpes Vaccine J. Inf. Dis. 170:1110-1119 (1994).
Sanchez Pescador et al. The Effect of Adjuvants on the Efficacy of a Recombinat Herpes Simplex Virus Glycoprotei Vaccine, J. of Immunology 141:1720-1727 1988.
Byars, et al. Vaccinating Guinea Pigs with Recombinant Glycoprotein D of Herpes Simplex Virus in a Efficacious Adjuvant Formulation Elicits Protection Against Vaginal Infection, Vaccine 12:200-209, 1994.
Berman et al., Science (1985) 227:1490-1492.
Bzik et al., Virology (1984) 133:301-314.
Cappel et al., J. Med. Virol. (1985) 16: 137-145.
Chan, Immunology (1983) 49:343-352.
Cohen et al., J. Virol. (1984) 49:102-108.
DeLucca et al., Virology (1982) 122:411-423.
Dundarov et al., Devel. Biol. Standard. (1982) 52:351-357.
Eberle et al., J. Infect. Dis. (1983) 148:436-444.
Hilfenhaus et al., Devel. Biol. Standard. (1982) 52:321-331.
Lasky et al., Biotechnology (Jun. 1984) pp. 527-532.
Marsden et al., J. Virol. (1978) 28:624-642.
Pellet et al., J. Virol. (1985) 53:243-253.
Roizman et al., Ann. Rev. Genet. (1979) 13:25-57.
Ruyechan et al., J. Virol. (1979) 29:677-697.
Skare et al., Virology (1977) 76:581-595.
Skinner et al., Devel. Biol. Standard. (1982) 52:333-344.
Watson et al., Science (1982) 218:381-384.
Weis et al., Nature (1983) 302:72-74.
Burke Rae L.
Pachl Carol
Valenzuela Pablo D.T.
Blackburn Robert P.
Chiron Corporation
McClung Barbara G.
Mosher Mary E.
Robins Roberta L.
LandOfFree
Expression of recombinant glycoprotein B from herpes simplex vir does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Expression of recombinant glycoprotein B from herpes simplex vir, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Expression of recombinant glycoprotein B from herpes simplex vir will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1458528